THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL;THE ROYAL MARSDEN NHS FOUNDATION TRUST; ROYAL CANCER HOSPITAL;THE INSTITUTE OF CANCER RESEARCH
发明人:
BANERJI, UDAI
申请号：
CA3082619
公开号：
CA3082619A1
申请日:
2018.05.16
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present invention provides a medicament for the treatment or prevention of a cell proliferative disorder, the medicament comprising as an active ingredient a compound represented by formula or a pharmaceutically acceptable salt thereof, wherein the medicament is used in such a manner that: (a) said compound or salt is administered twice weekly for 3 weeks, (b) administration of said compound or salt is paused for the following 1 week, and (c) steps (a) and (b) are subsequently repeated at least once.
